nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GLYATL1—respiratory system—lung cancer	0.0124	0.0476	CbGeAlD
Glycine—ALAS2—respiratory system—lung cancer	0.00882	0.0339	CbGeAlD
Glycine—GLYATL2—bronchus—lung cancer	0.00866	0.0333	CbGeAlD
Glycine—GLYATL2—trachea—lung cancer	0.00778	0.0299	CbGeAlD
Glycine—ALAS1—mammary gland—lung cancer	0.00755	0.029	CbGeAlD
Glycine—Diuresis—Vinorelbine—lung cancer	0.00717	0.0297	CcSEcCtD
Glycine—GARS—mammary gland—lung cancer	0.00687	0.0264	CbGeAlD
Glycine—GPR18—bronchus—lung cancer	0.00672	0.0258	CbGeAlD
Glycine—GLYATL1—lung—lung cancer	0.00657	0.0253	CbGeAlD
Glycine—Toxicity to various agents—Irinotecan—lung cancer	0.00641	0.0266	CcSEcCtD
Glycine—GLYATL2—bone marrow—lung cancer	0.00617	0.0237	CbGeAlD
Glycine—SHMT2—mammary gland—lung cancer	0.00598	0.023	CbGeAlD
Glycine—GCAT—respiratory system—lung cancer	0.00574	0.022	CbGeAlD
Glycine—GLRB—mammary gland—lung cancer	0.0056	0.0215	CbGeAlD
Glycine—SHMT1—mammary gland—lung cancer	0.00544	0.0209	CbGeAlD
Glycine—Diuresis—Cisplatin—lung cancer	0.00537	0.0223	CcSEcCtD
Glycine—Electrolyte imbalance—Vinorelbine—lung cancer	0.00532	0.0221	CcSEcCtD
Glycine—ALAS2—bone marrow—lung cancer	0.00517	0.0199	CbGeAlD
Glycine—ALAS1—respiratory system—lung cancer	0.00503	0.0193	CbGeAlD
Glycine—Blindness transient—Methotrexate—lung cancer	0.005	0.0207	CcSEcCtD
Glycine—GRIN3B—lung—lung cancer	0.00498	0.0191	CbGeAlD
Glycine—PIPOX—bronchus—lung cancer	0.00487	0.0187	CbGeAlD
Glycine—L-Cysteine—GCLC—lung cancer	0.00479	1	CrCbGaD
Glycine—GPR18—bone marrow—lung cancer	0.00478	0.0184	CbGeAlD
Glycine—Salivation—Irinotecan—lung cancer	0.00473	0.0196	CcSEcCtD
Glycine—GCAT—bronchus—lung cancer	0.00472	0.0181	CbGeAlD
Glycine—ALAS2—lung—lung cancer	0.00468	0.018	CbGeAlD
Glycine—GARS—respiratory system—lung cancer	0.00458	0.0176	CbGeAlD
Glycine—Electrolyte imbalance—Irinotecan—lung cancer	0.00439	0.0182	CcSEcCtD
Glycine—GPR18—lung—lung cancer	0.00433	0.0166	CbGeAlD
Glycine—GCAT—trachea—lung cancer	0.00424	0.0163	CbGeAlD
Glycine—ALAS1—bronchus—lung cancer	0.00414	0.0159	CbGeAlD
Glycine—GCSH—lung—lung cancer	0.00406	0.0156	CbGeAlD
Glycine—SHMT2—respiratory system—lung cancer	0.00399	0.0153	CbGeAlD
Glycine—GARS—bronchus—lung cancer	0.00377	0.0145	CbGeAlD
Glycine—ALAS1—trachea—lung cancer	0.00372	0.0143	CbGeAlD
Glycine—Lung disorder—Topotecan—lung cancer	0.00367	0.0152	CcSEcCtD
Glycine—SHMT1—Podofilox—Teniposide—lung cancer	0.00363	0.307	CbGdCrCtD
Glycine—Lung disorder—Erlotinib—lung cancer	0.00363	0.0151	CcSEcCtD
Glycine—Visual disturbance—Crizotinib—lung cancer	0.00363	0.015	CcSEcCtD
Glycine—Thrombophlebitis—Gefitinib—lung cancer	0.0036	0.015	CcSEcCtD
Glycine—Electrolyte imbalance—Paclitaxel—lung cancer	0.00358	0.0148	CcSEcCtD
Glycine—ALAS1—cardiac atrium—lung cancer	0.00349	0.0134	CbGeAlD
Glycine—SLC6A9—lymph node—lung cancer	0.00341	0.0131	CbGeAlD
Glycine—GARS—trachea—lung cancer	0.00339	0.013	CbGeAlD
Glycine—GLDC—lung—lung cancer	0.00336	0.0129	CbGeAlD
Glycine—GCAT—bone marrow—lung cancer	0.00336	0.0129	CbGeAlD
Glycine—GARS—cardiac atrium—lung cancer	0.00318	0.0122	CbGeAlD
Glycine—PIPOX—lung—lung cancer	0.00314	0.0121	CbGeAlD
Glycine—Lung disorder—Vinorelbine—lung cancer	0.00314	0.013	CcSEcCtD
Glycine—GCAT—lung—lung cancer	0.00305	0.0117	CbGeAlD
Glycine—GATM—cardiac atrium—lung cancer	0.00302	0.0116	CbGeAlD
Glycine—SHMT1—bronchus—lung cancer	0.00299	0.0115	CbGeAlD
Glycine—GPR18—lymph node—lung cancer	0.00296	0.0114	CbGeAlD
Glycine—ALAS1—bone marrow—lung cancer	0.00295	0.0113	CbGeAlD
Glycine—Cardiovascular disorder—Erlotinib—lung cancer	0.00292	0.0121	CcSEcCtD
Glycine—Dehydration—Pemetrexed—lung cancer	0.00292	0.0121	CcSEcCtD
Glycine—Dehydration—Gefitinib—lung cancer	0.0029	0.012	CcSEcCtD
Glycine—GCSH—lymph node—lung cancer	0.00278	0.0107	CbGeAlD
Glycine—GSS—respiratory system—lung cancer	0.00272	0.0105	CbGeAlD
Glycine—GARS—bone marrow—lung cancer	0.00268	0.0103	CbGeAlD
Glycine—SHMT1—trachea—lung cancer	0.00268	0.0103	CbGeAlD
Glycine—Fluid overload—Cisplatin—lung cancer	0.00268	0.0111	CcSEcCtD
Glycine—ALAS1—lung—lung cancer	0.00267	0.0103	CbGeAlD
Glycine—Angina pectoris—Pemetrexed—lung cancer	0.00264	0.011	CcSEcCtD
Glycine—Lung disorder—Irinotecan—lung cancer	0.00259	0.0107	CcSEcCtD
Glycine—GARS—lung—lung cancer	0.00243	0.00935	CbGeAlD
Glycine—SHMT2—bone marrow—lung cancer	0.00234	0.00897	CbGeAlD
Glycine—Encephalopathy—Paclitaxel—lung cancer	0.00233	0.00966	CcSEcCtD
Glycine—SHMT1—Vincristine—Vinorelbine—lung cancer	0.00231	0.196	CbGdCrCtD
Glycine—GATM—lung—lung cancer	0.00231	0.00887	CbGeAlD
Glycine—GLDC—lymph node—lung cancer	0.0023	0.00884	CbGeAlD
Glycine—Visual impairment—Crizotinib—lung cancer	0.00229	0.0095	CcSEcCtD
Glycine—GSS—bronchus—lung cancer	0.00224	0.00862	CbGeAlD
Glycine—SHMT1—Podofilox—Etoposide—lung cancer	0.00216	0.183	CbGdCrCtD
Glycine—SHMT1—bone marrow—lung cancer	0.00213	0.00817	CbGeAlD
Glycine—SHMT2—lung—lung cancer	0.00212	0.00813	CbGeAlD
Glycine—GCAT—lymph node—lung cancer	0.00208	0.00801	CbGeAlD
Glycine—GSS—trachea—lung cancer	0.00201	0.00774	CbGeAlD
Glycine—GLRB—lung—lung cancer	0.00198	0.00762	CbGeAlD
Glycine—Vision blurred—Crizotinib—lung cancer	0.00195	0.00809	CcSEcCtD
Glycine—SHMT1—lung—lung cancer	0.00193	0.0074	CbGeAlD
Glycine—GSS—cardiac atrium—lung cancer	0.00189	0.00727	CbGeAlD
Glycine—Thrombophlebitis—Vinorelbine—lung cancer	0.00186	0.00773	CcSEcCtD
Glycine—SHMT1—Vinblastine—Vinorelbine—lung cancer	0.00186	0.157	CbGdCrCtD
Glycine—SHMT1—Vincristine—Vinblastine—lung cancer	0.00185	0.156	CbGdCrCtD
Glycine—Polyuria—Vinorelbine—lung cancer	0.00184	0.00762	CcSEcCtD
Glycine—ALAS1—lymph node—lung cancer	0.00183	0.00702	CbGeAlD
Glycine—SLC36A1—bone marrow—lung cancer	0.00181	0.00697	CbGeAlD
Glycine—Salivary hypersecretion—Irinotecan—lung cancer	0.00178	0.00738	CcSEcCtD
Glycine—Dehydration—Erlotinib—lung cancer	0.00173	0.0072	CcSEcCtD
Glycine—Cardiovascular disorder—Etoposide—lung cancer	0.00173	0.0072	CcSEcCtD
Glycine—Oedema—Crizotinib—lung cancer	0.00169	0.00701	CcSEcCtD
Glycine—SLC16A10—epithelium—lung cancer	0.00167	0.00641	CbGeAlD
Glycine—GARS—lymph node—lung cancer	0.00166	0.00639	CbGeAlD
Glycine—SLC36A1—lung—lung cancer	0.00164	0.00631	CbGeAlD
Glycine—Angina pectoris—Vinblastine—lung cancer	0.00163	0.00678	CcSEcCtD
Glycine—Hyponatraemia—Vinorelbine—lung cancer	0.00162	0.00672	CcSEcCtD
Glycine—GSS—bone marrow—lung cancer	0.0016	0.00614	CbGeAlD
Glycine—GATM—lymph node—lung cancer	0.00158	0.00607	CbGeAlD
Glycine—Chills—Teniposide—lung cancer	0.00158	0.00655	CcSEcCtD
Glycine—Oedema—Pemetrexed—lung cancer	0.00154	0.0064	CcSEcCtD
Glycine—Thrombophlebitis—Irinotecan—lung cancer	0.00154	0.00637	CcSEcCtD
Glycine—SHMT2—lymph node—lung cancer	0.00145	0.00556	CbGeAlD
Glycine—GSS—lung—lung cancer	0.00145	0.00556	CbGeAlD
Glycine—Hypotension—Gefitinib—lung cancer	0.00143	0.00595	CcSEcCtD
Glycine—Encephalopathy—Methotrexate—lung cancer	0.00142	0.0059	CcSEcCtD
Glycine—Visual disturbance—Irinotecan—lung cancer	0.0014	0.00582	CcSEcCtD
Glycine—Polyuria—Cisplatin—lung cancer	0.00138	0.00571	CcSEcCtD
Glycine—Angina pectoris—Vinorelbine—lung cancer	0.00136	0.00563	CcSEcCtD
Glycine—GLRB—lymph node—lung cancer	0.00136	0.00521	CbGeAlD
Glycine—Lightheadedness—Paclitaxel—lung cancer	0.00134	0.00555	CcSEcCtD
Glycine—Hyponatraemia—Irinotecan—lung cancer	0.00134	0.00554	CcSEcCtD
Glycine—Pain—Pemetrexed—lung cancer	0.00132	0.00548	CcSEcCtD
Glycine—SHMT1—lymph node—lung cancer	0.00132	0.00506	CbGeAlD
Glycine—Pain—Gefitinib—lung cancer	0.00131	0.00544	CcSEcCtD
Glycine—Rhinitis—Topotecan—lung cancer	0.00131	0.00542	CcSEcCtD
Glycine—Lung disorder—Methotrexate—lung cancer	0.00129	0.00535	CcSEcCtD
Glycine—Thrombophlebitis—Paclitaxel—lung cancer	0.00125	0.0052	CcSEcCtD
Glycine—Oedema—Teniposide—lung cancer	0.00125	0.00519	CcSEcCtD
Glycine—Dehydration—Irinotecan—lung cancer	0.00124	0.00513	CcSEcCtD
Glycine—Polyuria—Paclitaxel—lung cancer	0.00124	0.00513	CcSEcCtD
Glycine—Urticaria—Pemetrexed—lung cancer	0.00123	0.00509	CcSEcCtD
Glycine—Tachycardia—Teniposide—lung cancer	0.00122	0.00506	CcSEcCtD
Glycine—Urticaria—Gefitinib—lung cancer	0.00122	0.00505	CcSEcCtD
Glycine—Hyponatraemia—Cisplatin—lung cancer	0.00121	0.00503	CcSEcCtD
Glycine—Chills—Topotecan—lung cancer	0.00117	0.00486	CcSEcCtD
Glycine—Hypotension—Teniposide—lung cancer	0.00117	0.00485	CcSEcCtD
Glycine—Chills—Erlotinib—lung cancer	0.00116	0.0048	CcSEcCtD
Glycine—Diarrhoea—Crizotinib—lung cancer	0.00116	0.00479	CcSEcCtD
Glycine—Visual disturbance—Paclitaxel—lung cancer	0.00114	0.00475	CcSEcCtD
Glycine—Hypersensitivity—Pemetrexed—lung cancer	0.00114	0.00472	CcSEcCtD
Glycine—Lightheadedness—Docetaxel—lung cancer	0.00113	0.0047	CcSEcCtD
Glycine—Hypersensitivity—Gefitinib—lung cancer	0.00113	0.00469	CcSEcCtD
Glycine—SLC36A1—lymph node—lung cancer	0.00112	0.00432	CbGeAlD
Glycine—Dehydration—Cisplatin—lung cancer	0.00112	0.00466	CcSEcCtD
Glycine—Angina pectoris—Irinotecan—lung cancer	0.00112	0.00465	CcSEcCtD
Glycine—Lung disorder—Doxorubicin—lung cancer	0.00112	0.00463	CcSEcCtD
Glycine—Dizziness—Crizotinib—lung cancer	0.00112	0.00463	CcSEcCtD
Glycine—Back pain—Topotecan—lung cancer	0.0011	0.00456	CcSEcCtD
Glycine—Hyponatraemia—Paclitaxel—lung cancer	0.00109	0.00452	CcSEcCtD
Glycine—Back pain—Erlotinib—lung cancer	0.00109	0.00451	CcSEcCtD
Glycine—Vomiting—Crizotinib—lung cancer	0.00107	0.00446	CcSEcCtD
Glycine—Thrombophlebitis—Docetaxel—lung cancer	0.00106	0.00441	CcSEcCtD
Glycine—SLC16A10—lung—lung cancer	0.00106	0.00407	CbGeAlD
Glycine—Diarrhoea—Pemetrexed—lung cancer	0.00106	0.00438	CcSEcCtD
Glycine—Vertigo—Vinblastine—lung cancer	0.00105	0.00436	CcSEcCtD
Glycine—Diarrhoea—Gefitinib—lung cancer	0.00105	0.00435	CcSEcCtD
Glycine—Dizziness—Pemetrexed—lung cancer	0.00102	0.00423	CcSEcCtD
Glycine—Convulsion—Vinblastine—lung cancer	0.00101	0.0042	CcSEcCtD
Glycine—Dehydration—Paclitaxel—lung cancer	0.00101	0.00419	CcSEcCtD
Glycine—Nausea—Crizotinib—lung cancer	0.001	0.00416	CcSEcCtD
Glycine—Urticaria—Teniposide—lung cancer	0.000993	0.00412	CcSEcCtD
Glycine—GSS—lymph node—lung cancer	0.000989	0.0038	CbGeAlD
Glycine—Vomiting—Pemetrexed—lung cancer	0.000981	0.00407	CcSEcCtD
Glycine—Vomiting—Gefitinib—lung cancer	0.000975	0.00405	CcSEcCtD
Glycine—Visual disturbance—Docetaxel—lung cancer	0.00097	0.00403	CcSEcCtD
Glycine—Back pain—Vinorelbine—lung cancer	0.00094	0.0039	CcSEcCtD
Glycine—Hyponatraemia—Docetaxel—lung cancer	0.000923	0.00383	CcSEcCtD
Glycine—Rhinitis—Irinotecan—lung cancer	0.000923	0.00383	CcSEcCtD
Glycine—Hypersensitivity—Teniposide—lung cancer	0.000921	0.00382	CcSEcCtD
Glycine—Oedema—Erlotinib—lung cancer	0.000917	0.0038	CcSEcCtD
Glycine—Nausea—Pemetrexed—lung cancer	0.000917	0.0038	CcSEcCtD
Glycine—Nausea—Gefitinib—lung cancer	0.000911	0.00378	CcSEcCtD
Glycine—Cardiovascular disorder—Doxorubicin—lung cancer	0.0009	0.00373	CcSEcCtD
Glycine—Rhinitis—Gemcitabine—lung cancer	0.000899	0.00373	CcSEcCtD
Glycine—Visual impairment—Irinotecan—lung cancer	0.000887	0.00368	CcSEcCtD
Glycine—Vertigo—Vinorelbine—lung cancer	0.000873	0.00362	CcSEcCtD
Glycine—Diarrhoea—Teniposide—lung cancer	0.000855	0.00355	CcSEcCtD
Glycine—Dehydration—Docetaxel—lung cancer	0.000855	0.00355	CcSEcCtD
Glycine—Coma—Methotrexate—lung cancer	0.000834	0.00346	CcSEcCtD
Glycine—Chills—Irinotecan—lung cancer	0.000826	0.00343	CcSEcCtD
Glycine—Pain—Vinblastine—lung cancer	0.000816	0.00338	CcSEcCtD
Glycine—Visual impairment—Cisplatin—lung cancer	0.000805	0.00334	CcSEcCtD
Glycine—Chills—Gemcitabine—lung cancer	0.000804	0.00334	CcSEcCtD
Glycine—Vomiting—Teniposide—lung cancer	0.000795	0.0033	CcSEcCtD
Glycine—Pain—Topotecan—lung cancer	0.000792	0.00329	CcSEcCtD
Glycine—Pain—Erlotinib—lung cancer	0.000784	0.00325	CcSEcCtD
Glycine—Back pain—Irinotecan—lung cancer	0.000775	0.00321	CcSEcCtD
Glycine—Angina pectoris—Docetaxel—lung cancer	0.000774	0.00321	CcSEcCtD
Glycine—Tachycardia—Vinorelbine—lung cancer	0.000774	0.00321	CcSEcCtD
Glycine—Salivary hypersecretion—Doxorubicin—lung cancer	0.000768	0.00319	CcSEcCtD
Glycine—Thrombophlebitis—Methotrexate—lung cancer	0.000766	0.00318	CcSEcCtD
Glycine—Back pain—Gemcitabine—lung cancer	0.000755	0.00313	CcSEcCtD
Glycine—Polyuria—Methotrexate—lung cancer	0.000755	0.00313	CcSEcCtD
Glycine—Rhinitis—Paclitaxel—lung cancer	0.000752	0.00312	CcSEcCtD
Glycine—Nausea—Teniposide—lung cancer	0.000743	0.00308	CcSEcCtD
Glycine—Hypotension—Vinorelbine—lung cancer	0.000741	0.00307	CcSEcCtD
Glycine—Urticaria—Topotecan—lung cancer	0.000736	0.00305	CcSEcCtD
Glycine—SLC16A10—lymph node—lung cancer	0.000725	0.00278	CbGeAlD
Glycine—Visual impairment—Paclitaxel—lung cancer	0.000723	0.003	CcSEcCtD
Glycine—Coma—Doxorubicin—lung cancer	0.000722	0.003	CcSEcCtD
Glycine—Vertigo—Irinotecan—lung cancer	0.00072	0.00299	CcSEcCtD
Glycine—Hypersensitivity—Vinblastine—lung cancer	0.000703	0.00292	CcSEcCtD
Glycine—Visual disturbance—Methotrexate—lung cancer	0.000699	0.0029	CcSEcCtD
Glycine—Chills—Etoposide—lung cancer	0.000687	0.00285	CcSEcCtD
Glycine—Vision blurred—Cisplatin—lung cancer	0.000685	0.00284	CcSEcCtD
Glycine—Hypersensitivity—Topotecan—lung cancer	0.000683	0.00283	CcSEcCtD
Glycine—Pain—Vinorelbine—lung cancer	0.000678	0.00281	CcSEcCtD
Glycine—Chills—Paclitaxel—lung cancer	0.000673	0.00279	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—lung cancer	0.000663	0.00275	CcSEcCtD
Glycine—Oedema—Irinotecan—lung cancer	0.000654	0.00271	CcSEcCtD
Glycine—Diarrhoea—Vinblastine—lung cancer	0.000653	0.00271	CcSEcCtD
Glycine—Back pain—Etoposide—lung cancer	0.000645	0.00267	CcSEcCtD
Glycine—Rhinitis—Docetaxel—lung cancer	0.000638	0.00265	CcSEcCtD
Glycine—Oedema—Gemcitabine—lung cancer	0.000637	0.00264	CcSEcCtD
Glycine—Diarrhoea—Topotecan—lung cancer	0.000634	0.00263	CcSEcCtD
Glycine—Back pain—Paclitaxel—lung cancer	0.000632	0.00262	CcSEcCtD
Glycine—Dizziness—Vinblastine—lung cancer	0.000631	0.00262	CcSEcCtD
Glycine—Convulsion—Cisplatin—lung cancer	0.00063	0.00261	CcSEcCtD
Glycine—Urticaria—Vinorelbine—lung cancer	0.00063	0.00261	CcSEcCtD
Glycine—Diarrhoea—Erlotinib—lung cancer	0.000627	0.0026	CcSEcCtD
Glycine—Vision blurred—Paclitaxel—lung cancer	0.000616	0.00255	CcSEcCtD
Glycine—Visual impairment—Docetaxel—lung cancer	0.000613	0.00254	CcSEcCtD
Glycine—Dizziness—Topotecan—lung cancer	0.000613	0.00254	CcSEcCtD
Glycine—Hypotension—Irinotecan—lung cancer	0.000611	0.00253	CcSEcCtD
Glycine—Vomiting—Vinblastine—lung cancer	0.000606	0.00252	CcSEcCtD
Glycine—Dizziness—Erlotinib—lung cancer	0.000606	0.00252	CcSEcCtD
Glycine—Vertigo—Etoposide—lung cancer	0.000599	0.00248	CcSEcCtD
Glycine—Hypotension—Gemcitabine—lung cancer	0.000595	0.00247	CcSEcCtD
Glycine—Oedema—Cisplatin—lung cancer	0.000594	0.00246	CcSEcCtD
Glycine—Vomiting—Topotecan—lung cancer	0.000589	0.00244	CcSEcCtD
Glycine—Vertigo—Paclitaxel—lung cancer	0.000587	0.00244	CcSEcCtD
Glycine—Hypersensitivity—Vinorelbine—lung cancer	0.000584	0.00242	CcSEcCtD
Glycine—Vomiting—Erlotinib—lung cancer	0.000583	0.00242	CcSEcCtD
Glycine—Tachycardia—Cisplatin—lung cancer	0.000579	0.0024	CcSEcCtD
Glycine—Convulsion—Etoposide—lung cancer	0.000577	0.0024	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—lung cancer	0.000576	0.00239	CcSEcCtD
Glycine—Chills—Docetaxel—lung cancer	0.000571	0.00237	CcSEcCtD
Glycine—Nausea—Vinblastine—lung cancer	0.000567	0.00235	CcSEcCtD
Glycine—Convulsion—Paclitaxel—lung cancer	0.000566	0.00235	CcSEcCtD
Glycine—Pain—Irinotecan—lung cancer	0.000559	0.00232	CcSEcCtD
Glycine—Hypotension—Cisplatin—lung cancer	0.000555	0.0023	CcSEcCtD
Glycine—Nausea—Topotecan—lung cancer	0.00055	0.00228	CcSEcCtD
Glycine—Pain—Gemcitabine—lung cancer	0.000545	0.00226	CcSEcCtD
Glycine—Nausea—Erlotinib—lung cancer	0.000545	0.00226	CcSEcCtD
Glycine—Diarrhoea—Vinorelbine—lung cancer	0.000542	0.00225	CcSEcCtD
Glycine—Back pain—Docetaxel—lung cancer	0.000536	0.00222	CcSEcCtD
Glycine—Dehydration—Doxorubicin—lung cancer	0.000534	0.00221	CcSEcCtD
Glycine—Oedema—Paclitaxel—lung cancer	0.000533	0.00221	CcSEcCtD
Glycine—Tachycardia—Etoposide—lung cancer	0.000531	0.0022	CcSEcCtD
Glycine—Dizziness—Vinorelbine—lung cancer	0.000524	0.00217	CcSEcCtD
Glycine—Tachycardia—Paclitaxel—lung cancer	0.00052	0.00216	CcSEcCtD
Glycine—Hypotension—Etoposide—lung cancer	0.000508	0.00211	CcSEcCtD
Glycine—Pain—Cisplatin—lung cancer	0.000508	0.00211	CcSEcCtD
Glycine—Vomiting—Vinorelbine—lung cancer	0.000504	0.00209	CcSEcCtD
Glycine—Hypotension—Paclitaxel—lung cancer	0.000498	0.00207	CcSEcCtD
Glycine—Angina pectoris—Doxorubicin—lung cancer	0.000483	0.002	CcSEcCtD
Glycine—Hypersensitivity—Irinotecan—lung cancer	0.000482	0.002	CcSEcCtD
Glycine—Convulsion—Docetaxel—lung cancer	0.00048	0.00199	CcSEcCtD
Glycine—Nausea—Vinorelbine—lung cancer	0.000471	0.00195	CcSEcCtD
Glycine—Pain—Etoposide—lung cancer	0.000465	0.00193	CcSEcCtD
Glycine—Pain—Paclitaxel—lung cancer	0.000456	0.00189	CcSEcCtD
Glycine—Oedema—Docetaxel—lung cancer	0.000452	0.00187	CcSEcCtD
Glycine—Diarrhoea—Irinotecan—lung cancer	0.000447	0.00186	CcSEcCtD
Glycine—Visual impairment—Methotrexate—lung cancer	0.000442	0.00183	CcSEcCtD
Glycine—Tachycardia—Docetaxel—lung cancer	0.000441	0.00183	CcSEcCtD
Glycine—Hypersensitivity—Cisplatin—lung cancer	0.000437	0.00181	CcSEcCtD
Glycine—Diarrhoea—Gemcitabine—lung cancer	0.000436	0.00181	CcSEcCtD
Glycine—Dizziness—Irinotecan—lung cancer	0.000432	0.00179	CcSEcCtD
Glycine—Urticaria—Etoposide—lung cancer	0.000432	0.00179	CcSEcCtD
Glycine—Urticaria—Paclitaxel—lung cancer	0.000424	0.00176	CcSEcCtD
Glycine—Hypotension—Docetaxel—lung cancer	0.000422	0.00175	CcSEcCtD
Glycine—Vomiting—Irinotecan—lung cancer	0.000416	0.00172	CcSEcCtD
Glycine—Chills—Methotrexate—lung cancer	0.000411	0.00171	CcSEcCtD
Glycine—Diarrhoea—Cisplatin—lung cancer	0.000406	0.00168	CcSEcCtD
Glycine—Vomiting—Gemcitabine—lung cancer	0.000405	0.00168	CcSEcCtD
Glycine—Hypersensitivity—Etoposide—lung cancer	0.000401	0.00166	CcSEcCtD
Glycine—Rhinitis—Doxorubicin—lung cancer	0.000398	0.00165	CcSEcCtD
Glycine—Hypersensitivity—Paclitaxel—lung cancer	0.000393	0.00163	CcSEcCtD
Glycine—Nausea—Irinotecan—lung cancer	0.000388	0.00161	CcSEcCtD
Glycine—Pain—Docetaxel—lung cancer	0.000386	0.0016	CcSEcCtD
Glycine—Back pain—Methotrexate—lung cancer	0.000386	0.0016	CcSEcCtD
Glycine—Visual impairment—Doxorubicin—lung cancer	0.000383	0.00159	CcSEcCtD
Glycine—Nausea—Gemcitabine—lung cancer	0.000378	0.00157	CcSEcCtD
Glycine—Vomiting—Cisplatin—lung cancer	0.000377	0.00157	CcSEcCtD
Glycine—Vision blurred—Methotrexate—lung cancer	0.000376	0.00156	CcSEcCtD
Glycine—Diarrhoea—Etoposide—lung cancer	0.000372	0.00154	CcSEcCtD
Glycine—Diarrhoea—Paclitaxel—lung cancer	0.000365	0.00151	CcSEcCtD
Glycine—Dizziness—Etoposide—lung cancer	0.00036	0.00149	CcSEcCtD
Glycine—Vertigo—Methotrexate—lung cancer	0.000359	0.00149	CcSEcCtD
Glycine—Chills—Doxorubicin—lung cancer	0.000356	0.00148	CcSEcCtD
Glycine—Dizziness—Paclitaxel—lung cancer	0.000353	0.00146	CcSEcCtD
Glycine—Nausea—Cisplatin—lung cancer	0.000353	0.00146	CcSEcCtD
Glycine—Convulsion—Methotrexate—lung cancer	0.000346	0.00143	CcSEcCtD
Glycine—Vomiting—Etoposide—lung cancer	0.000346	0.00143	CcSEcCtD
Glycine—Vomiting—Paclitaxel—lung cancer	0.000339	0.00141	CcSEcCtD
Glycine—Back pain—Doxorubicin—lung cancer	0.000334	0.00139	CcSEcCtD
Glycine—Hypersensitivity—Docetaxel—lung cancer	0.000333	0.00138	CcSEcCtD
Glycine—Vision blurred—Doxorubicin—lung cancer	0.000326	0.00135	CcSEcCtD
Glycine—Nausea—Etoposide—lung cancer	0.000323	0.00134	CcSEcCtD
Glycine—Nausea—Paclitaxel—lung cancer	0.000317	0.00131	CcSEcCtD
Glycine—Vertigo—Doxorubicin—lung cancer	0.00031	0.00129	CcSEcCtD
Glycine—Diarrhoea—Docetaxel—lung cancer	0.000309	0.00128	CcSEcCtD
Glycine—Hypotension—Methotrexate—lung cancer	0.000304	0.00126	CcSEcCtD
Glycine—Convulsion—Doxorubicin—lung cancer	0.000299	0.00124	CcSEcCtD
Glycine—Dizziness—Docetaxel—lung cancer	0.000299	0.00124	CcSEcCtD
Glycine—Vomiting—Docetaxel—lung cancer	0.000287	0.00119	CcSEcCtD
Glycine—Oedema—Doxorubicin—lung cancer	0.000282	0.00117	CcSEcCtD
Glycine—Pain—Methotrexate—lung cancer	0.000279	0.00116	CcSEcCtD
Glycine—Tachycardia—Doxorubicin—lung cancer	0.000275	0.00114	CcSEcCtD
Glycine—Nausea—Docetaxel—lung cancer	0.000268	0.00111	CcSEcCtD
Glycine—Hypotension—Doxorubicin—lung cancer	0.000264	0.00109	CcSEcCtD
Glycine—Urticaria—Methotrexate—lung cancer	0.000259	0.00107	CcSEcCtD
Glycine—Pain—Doxorubicin—lung cancer	0.000241	0.001	CcSEcCtD
Glycine—Hypersensitivity—Methotrexate—lung cancer	0.00024	0.000996	CcSEcCtD
Glycine—Urticaria—Doxorubicin—lung cancer	0.000224	0.00093	CcSEcCtD
Glycine—Diarrhoea—Methotrexate—lung cancer	0.000223	0.000925	CcSEcCtD
Glycine—Dizziness—Methotrexate—lung cancer	0.000215	0.000894	CcSEcCtD
Glycine—Hypersensitivity—Doxorubicin—lung cancer	0.000208	0.000862	CcSEcCtD
Glycine—Vomiting—Methotrexate—lung cancer	0.000207	0.000859	CcSEcCtD
Glycine—Nausea—Methotrexate—lung cancer	0.000193	0.000803	CcSEcCtD
Glycine—Diarrhoea—Doxorubicin—lung cancer	0.000193	0.000801	CcSEcCtD
Glycine—Dizziness—Doxorubicin—lung cancer	0.000187	0.000774	CcSEcCtD
Glycine—Vomiting—Doxorubicin—lung cancer	0.000179	0.000744	CcSEcCtD
Glycine—Nausea—Doxorubicin—lung cancer	0.000168	0.000695	CcSEcCtD
Glycine—GLRA1—Transmembrane transport of small molecules—RAF1—lung cancer	4.86e-05	0.000101	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP2E1—lung cancer	4.82e-05	9.99e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—AVP—lung cancer	4.81e-05	9.97e-05	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ALB—lung cancer	4.79e-05	9.94e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CB—lung cancer	4.77e-05	9.9e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NQO1—lung cancer	4.76e-05	9.88e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ABCB1—lung cancer	4.73e-05	9.82e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTGS2—lung cancer	4.73e-05	9.81e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.72e-05	9.79e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CG—lung cancer	4.72e-05	9.79e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CG—lung cancer	4.72e-05	9.79e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CG—lung cancer	4.72e-05	9.79e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CG—lung cancer	4.72e-05	9.79e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—lung cancer	4.7e-05	9.75e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TERT—lung cancer	4.68e-05	9.71e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ABCB1—lung cancer	4.65e-05	9.65e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—TYMS—lung cancer	4.65e-05	9.64e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTM1—lung cancer	4.59e-05	9.53e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGFR1—lung cancer	4.55e-05	9.43e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—MAPK3—lung cancer	4.53e-05	9.4e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CG—lung cancer	4.5e-05	9.34e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HES1—lung cancer	4.5e-05	9.33e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—POMC—lung cancer	4.49e-05	9.32e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—POMC—lung cancer	4.49e-05	9.32e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—POMC—lung cancer	4.49e-05	9.32e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—POMC—lung cancer	4.49e-05	9.32e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HIF1A—lung cancer	4.48e-05	9.29e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—lung cancer	4.41e-05	9.14e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—STK11—lung cancer	4.41e-05	9.14e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—APOA1—lung cancer	4.4e-05	9.12e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CREBBP—lung cancer	4.38e-05	9.07e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—CREBBP—lung cancer	4.38e-05	9.07e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CREBBP—lung cancer	4.38e-05	9.07e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CREBBP—lung cancer	4.38e-05	9.07e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP1A1—lung cancer	4.36e-05	9.03e-05	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—RAF1—lung cancer	4.33e-05	8.99e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APOA1—lung cancer	4.32e-05	8.96e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ERCC2—lung cancer	4.32e-05	8.96e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—STK11—lung cancer	4.29e-05	8.9e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—POMC—lung cancer	4.29e-05	8.89e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KDR—lung cancer	4.28e-05	8.88e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—APOA1—lung cancer	4.26e-05	8.83e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERCC2—lung cancer	4.21e-05	8.72e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—CREBBP—lung cancer	4.17e-05	8.66e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CD—lung cancer	4.15e-05	8.6e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CD—lung cancer	4.15e-05	8.6e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CD—lung cancer	4.15e-05	8.6e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CD—lung cancer	4.15e-05	8.6e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTEN—lung cancer	4.12e-05	8.55e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB3—lung cancer	4.11e-05	8.53e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ALB—lung cancer	4.1e-05	8.49e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—ALB—lung cancer	4.1e-05	8.49e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ALB—lung cancer	4.1e-05	8.49e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ALB—lung cancer	4.1e-05	8.49e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTP1—lung cancer	4.08e-05	8.45e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.08e-05	8.45e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CG—lung cancer	4.01e-05	8.32e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTP1—lung cancer	3.97e-05	8.24e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CAT—lung cancer	3.97e-05	8.23e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CD—lung cancer	3.96e-05	8.21e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APC—lung cancer	3.95e-05	8.18e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KIT—lung cancer	3.95e-05	8.18e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CG—lung cancer	3.95e-05	8.18e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—NRAS—lung cancer	3.95e-05	8.18e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TERT—lung cancer	3.94e-05	8.18e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—EP300—lung cancer	3.93e-05	8.16e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—ALB—lung cancer	3.91e-05	8.1e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGF—lung cancer	3.9e-05	8.09e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CG—lung cancer	3.89e-05	8.06e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CAT—lung cancer	3.87e-05	8.02e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCB1—lung cancer	3.86e-05	8e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGFR1—lung cancer	3.83e-05	7.94e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—POMC—lung cancer	3.82e-05	7.92e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TYMS—lung cancer	3.79e-05	7.86e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK3—lung cancer	3.78e-05	7.84e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HIF1A—lung cancer	3.77e-05	7.82e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCB1—lung cancer	3.76e-05	7.8e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—POMC—lung cancer	3.76e-05	7.79e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTM1—lung cancer	3.75e-05	7.77e-05	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—lung cancer	3.75e-05	7.77e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOA1—lung cancer	3.74e-05	7.75e-05	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—lung cancer	3.73e-05	7.74e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CREBBP—lung cancer	3.72e-05	7.72e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—BRAF—lung cancer	3.71e-05	7.69e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—POMC—lung cancer	3.7e-05	7.67e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—TYMS—lung cancer	3.69e-05	7.66e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—APOA1—lung cancer	3.68e-05	7.62e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6R—lung cancer	3.66e-05	7.6e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CREBBP—lung cancer	3.66e-05	7.59e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTM1—lung cancer	3.65e-05	7.57e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APOA1—lung cancer	3.64e-05	7.54e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CB—lung cancer	3.62e-05	7.5e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CB—lung cancer	3.62e-05	7.5e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CB—lung cancer	3.62e-05	7.5e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CB—lung cancer	3.62e-05	7.5e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CREBBP—lung cancer	3.6e-05	7.47e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—lung cancer	3.59e-05	7.46e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—lung cancer	3.58e-05	7.43e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—lung cancer	3.58e-05	7.43e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—lung cancer	3.58e-05	7.43e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—lung cancer	3.58e-05	7.43e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP1A1—lung cancer	3.55e-05	7.36e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CD—lung cancer	3.53e-05	7.32e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ERCC2—lung cancer	3.52e-05	7.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAP2K1—lung cancer	3.49e-05	7.24e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—ALB—lung cancer	3.48e-05	7.22e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CD—lung cancer	3.47e-05	7.19e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP1A1—lung cancer	3.46e-05	7.18e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CB—lung cancer	3.45e-05	7.15e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—lung cancer	3.44e-05	7.13e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ERCC2—lung cancer	3.43e-05	7.12e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—lung cancer	3.42e-05	7.09e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CD—lung cancer	3.42e-05	7.09e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CG—lung cancer	3.41e-05	7.08e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—lung cancer	3.4e-05	7.04e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ALB—lung cancer	3.37e-05	6.99e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KIT—lung cancer	3.32e-05	6.89e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APC—lung cancer	3.32e-05	6.89e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EGF—lung cancer	3.28e-05	6.81e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—POMC—lung cancer	3.25e-05	6.74e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CREBBP—lung cancer	3.16e-05	6.56e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTEN—lung cancer	3.12e-05	6.48e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTEN—lung cancer	3.12e-05	6.48e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTEN—lung cancer	3.12e-05	6.48e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTEN—lung cancer	3.12e-05	6.48e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—BRAF—lung cancer	3.12e-05	6.47e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—lung cancer	3.12e-05	6.47e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—CREBBP—lung cancer	3.11e-05	6.45e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MDM2—lung cancer	3.11e-05	6.45e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RAF1—lung cancer	3.1e-05	6.42e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6R—lung cancer	3.08e-05	6.4e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CREBBP—lung cancer	3.08e-05	6.39e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CB—lung cancer	3.07e-05	6.38e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—lung cancer	3.06e-05	6.35e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—lung cancer	3.06e-05	6.34e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—lung cancer	3.05e-05	6.32e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOA1—lung cancer	3.05e-05	6.32e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MTOR—lung cancer	3.02e-05	6.27e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CB—lung cancer	3.02e-05	6.27e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CD—lung cancer	3e-05	6.22e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTEN—lung cancer	2.98e-05	6.18e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—EP300—lung cancer	2.98e-05	6.18e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—EP300—lung cancer	2.98e-05	6.18e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—EP300—lung cancer	2.98e-05	6.18e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—EP300—lung cancer	2.98e-05	6.18e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CB—lung cancer	2.98e-05	6.18e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOA1—lung cancer	2.97e-05	6.16e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ALB—lung cancer	2.96e-05	6.14e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—lung cancer	2.95e-05	6.12e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAP2K1—lung cancer	2.94e-05	6.1e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CD—lung cancer	2.92e-05	6.06e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ALB—lung cancer	2.91e-05	6.04e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—lung cancer	2.91e-05	6.03e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL8—lung cancer	2.91e-05	6.03e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—lung cancer	2.89e-05	5.99e-05	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—lung cancer	2.86e-05	5.93e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—EP300—lung cancer	2.84e-05	5.9e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—lung cancer	2.81e-05	5.82e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CG—lung cancer	2.78e-05	5.77e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—lung cancer	2.78e-05	5.77e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—lung cancer	2.78e-05	5.76e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—lung cancer	2.76e-05	5.73e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CG—lung cancer	2.71e-05	5.62e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—lung cancer	2.71e-05	5.61e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JUN—lung cancer	2.7e-05	5.6e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTEN—lung cancer	2.66e-05	5.51e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—POMC—lung cancer	2.65e-05	5.49e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—RAF1—lung cancer	2.63e-05	5.46e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—lung cancer	2.63e-05	5.45e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1A—lung cancer	2.62e-05	5.43e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MDM2—lung cancer	2.62e-05	5.42e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CB—lung cancer	2.61e-05	5.42e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTEN—lung cancer	2.61e-05	5.42e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—RAF1—lung cancer	2.61e-05	5.41e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—lung cancer	2.59e-05	5.37e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—POMC—lung cancer	2.58e-05	5.35e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CREBBP—lung cancer	2.58e-05	5.35e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—lung cancer	2.58e-05	5.35e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTEN—lung cancer	2.57e-05	5.34e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—lung cancer	2.55e-05	5.29e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CB—lung cancer	2.54e-05	5.28e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTOR—lung cancer	2.54e-05	5.28e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CD4—lung cancer	2.54e-05	5.27e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—EP300—lung cancer	2.53e-05	5.26e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—lung cancer	2.52e-05	5.23e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CREBBP—lung cancer	2.51e-05	5.21e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EP300—lung cancer	2.49e-05	5.17e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—EP300—lung cancer	2.45e-05	5.09e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CD—lung cancer	2.44e-05	5.07e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SRC—lung cancer	2.42e-05	5.03e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ALB—lung cancer	2.41e-05	5.01e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CD—lung cancer	2.38e-05	4.94e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—lung cancer	2.38e-05	4.93e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—lung cancer	2.36e-05	4.89e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ALB—lung cancer	2.35e-05	4.88e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT3—lung cancer	2.34e-05	4.85e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NRAS—lung cancer	2.33e-05	4.83e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTEN—lung cancer	2.26e-05	4.69e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK3—lung cancer	2.23e-05	4.63e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—lung cancer	2.2e-05	4.57e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—lung cancer	2.2e-05	4.57e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—lung cancer	2.2e-05	4.57e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—lung cancer	2.2e-05	4.57e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1A—lung cancer	2.2e-05	4.57e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTEN—lung cancer	2.2e-05	4.56e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—lung cancer	2.17e-05	4.5e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—EP300—lung cancer	2.15e-05	4.47e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CB—lung cancer	2.13e-05	4.42e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—lung cancer	2.12e-05	4.4e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—lung cancer	2.11e-05	4.38e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—lung cancer	2.1e-05	4.36e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EP300—lung cancer	2.1e-05	4.35e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CB—lung cancer	2.08e-05	4.31e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—lung cancer	2.06e-05	4.27e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SRC—lung cancer	2.04e-05	4.23e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—lung cancer	2.01e-05	4.16e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT3—lung cancer	1.97e-05	4.08e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NRAS—lung cancer	1.96e-05	4.07e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK3—lung cancer	1.88e-05	3.9e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—lung cancer	1.87e-05	3.89e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—lung cancer	1.84e-05	3.82e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTEN—lung cancer	1.84e-05	3.82e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—lung cancer	1.83e-05	3.79e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—lung cancer	1.82e-05	3.77e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—lung cancer	1.8e-05	3.73e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—lung cancer	1.8e-05	3.73e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—lung cancer	1.8e-05	3.73e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—lung cancer	1.8e-05	3.73e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTEN—lung cancer	1.79e-05	3.72e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—lung cancer	1.79e-05	3.71e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—lung cancer	1.78e-05	3.7e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—EP300—lung cancer	1.76e-05	3.64e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—lung cancer	1.72e-05	3.56e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—EP300—lung cancer	1.71e-05	3.55e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—lung cancer	1.71e-05	3.54e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—lung cancer	1.69e-05	3.5e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—lung cancer	1.63e-05	3.39e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—lung cancer	1.59e-05	3.31e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—lung cancer	1.55e-05	3.22e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—lung cancer	1.53e-05	3.18e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—lung cancer	1.51e-05	3.12e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—lung cancer	1.48e-05	3.08e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—lung cancer	1.44e-05	2.98e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—lung cancer	1.37e-05	2.85e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—lung cancer	1.3e-05	2.7e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—lung cancer	1.3e-05	2.69e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—lung cancer	1.27e-05	2.63e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—lung cancer	1.27e-05	2.63e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—lung cancer	1.06e-05	2.2e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—lung cancer	1.03e-05	2.15e-05	CbGpPWpGaD
